Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 31722-535

3 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 31722-535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tenofovirstructure (Tenofovirstructure)

Tenofovirstructure (Tenofovirstructure)
Chemical structure of Tenofovir Disoproxil Fumarate, showing the detailed molecular arrangement of its components, including nucleoside analog and fumarate parts.*
FDA Label Image

Camber1 (Camber1)

FDA Label Image

Tenofovir-label (Tenofovir Label)

Tenofovir-label (Tenofovir Label)
Label for Tenofovir Disoproxil Fumarate Tablets 300 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label indicates an Rx only product with 30 tablets per package. Includes storage instructions, a barcode, manufacturer details including Hetero Labs Limited in India, and a US contact number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.